How to Get My Site Noticed: Steps for Securing Earned Media
*Recruitment & Retention
For many of us, marketing our studies is not an area of experience. To recruit and retain patients we must understand marketing and what it means to get in front of our target audience. In this session, we will focus on how you can work with sponsors and CROs to secure earned media placements and deliver messages that will position your site and study to get noticed.
Greg Adams, Director, Clinical Site Management, Pfizer
Blake Adams, SVP Marketing, Florence Healthcare
Ezekiel Fink, MD, CMO, Cedar Health Research
Riaan van Tonder, Vice President, Site Network, AES, part of Thermo Fisher Scientific
Communications Fundamentals for Stronger Relationships
*BD & Relationships
Hear best practices for establishing rapport and building strong industry partnerships from sites and sponsors. In this session, you will learn how to create valuable, long-term industry relationships by understanding the fundamentals of proactive and timely communication strategies.
Lele Simmons, VP, Business Development, Flourish Research
Wes Bonner, Chief Relationship Officer, Meridian Clinical Research
Lauren Chazal, MBA, Chief Business Development Officer, Headlands Research
Lindsey Morales, Senior Manager, Site Centric Solutions , Labcorp Drug Development
Nancy Trapp, Senior Director, North America Clinical Operations-Field Management, Novo Nordisk
Improving Study Visit Flow: Creating Efficiencies at Your Site
It doesn’t have to be this hard! Learn how to set up and execute your study visit effectively. This round table discussion will be packed with techniques that make a participant’s visit less burdensome and improve the experience for the participant and staff.
Lisa Bjornestad, VP, Clinical Operations, DM Clinical Research
Jean Lucas, MD, Principal Investigator, Lucas Research
Jamie Schimmel, MPA, VP, Clinical Research Operations, IMA Clinical Research
Chris Popple, VP, Strategic Development, Javara
Staff Retention: Keeping Your Staff Motivated & Engaged
Help wanted! Our panel will discuss methods to keep your most valuable assets: your employees. Learn methods for engaging your staff that will keep them long term and create a great company culture. Our panelist will also help you understand how the pandemic has changed the landscape of staffing your site and how to plan for the future.
Marianne Tadros, ACRP-PM, SHRM-CP, Director of Human Resources and Organizational Development, DM Clinical Research
Kay Scroggins, RN, President/CEO, Clinical Trials of Texas, part of Flourish Research
Alexis Shaffer, Sr. Business Development Director, National Life Sciences, Medix Life Sciences
Contracts & Clauses: What They Really Mean
In this session, you’ll get the ABCs and 123s of contracts. You don’t need to have a legal degree to understand a contract and its clauses, but you do need to have the tools and insights to know how to identify the major components of a CTA and how to fulfill contractual obligations. Get all you need to know in this session.
Michael Pierre, Sr. Director of Systems Management, Meridian Clinical Research
Christina Greene, JD, Head, Global Site Agreements, Merck
Brian Hunter, MA, VP, Contracts & Trial Management, CNS Healthcare
Lori Rich, VP of Strategic Development, Elligo Health Research
Innovative Methods to Revolutionize your Business Development Practices
*BD & Relationships
Revolutionize means to change something radically or fundamentally, so this panel talk is what you need for a fresh and innovative jolt for your site’s business development! Experts will share insights into technology, money, sponsorship, and participant needs. Be prepared to take notes and “level up!”
Andrew Kimball, MBA, Chief Commercial Officer, Meridian Clinical Research
Kerry Gorman, Head, NA Strategic Site Solutions, IQVIA
Alysa Langburt, Director, Business Development, Centricity Research
Kerri Mallory, MS, Study Start, Associate Director, GSK
Implementation & Integration of CTMS, eReg, & eSource Platforms
Join these industry experts as they share what changes are coming to your trials, what electronic platforms are currently available and what’s on the horizon. We’ll also discuss what is expected of a site and a sponsor, what is needed to keep your site operations compliant, and how to position your site to be competitive for new studies.
Raymond Nomizu, JD, CEO, CRIO
Stephanie Abbott, PharmD, Clinical Operations, Innovo Clinical Research-Western Washington Medical Group
Lydia Beaudette, MSc, CCRC, ACRP-PM, Director – Growth & Strategic Partnerships, Centricity Research
Stuart Cotter, VP, Product Management, Advarra
Jeff Stein, CEO & President, ALSA Research
Onboarding & Training New Staff: Efficient Ways to Ensure Quality & Success
Bring your new hires on board with intentional action to ensure their success in your company. Learn about successful staff training techniques and how to use what serves your site best. This panel will also discuss how these training techniques will drive quality and efficiency for your staff and your site.
Cesia Abea, Director of Finance, Clinical Site Partners – a Flourish Research Site
Mike Clay, MSJ, Chief Operating Officer, Javara
Penny O’Neal, RN, CCRC, Clinical Development Director, CNS Healthcare
Radhika Butula, MIPH, Manager, Medical Oncology Clinical Trials Unit, (MOCTU), CPMCC/Westmead Hospital
New Electronic Health Information & Data-Sharing Initiative: How It Impacts Sites
You may have heard about the Trusted Exchange Framework and Common Agreement (TEFCA) exchange program, but do you know what’s changed? In this session, learn all about TEFCA, how your site can benefit from data sharing, and how to ensure you stay compliant.
David Vulcano, LCSW, MBA, CIP, RAC, VP Clinical Research Compliance & Integrity, HCA Healthcare
Christina Krawiecki, MPH, Sr CRA, Oncology, Merck
Luis Magalhaes, MBA, Head of Site Network, Clinerion
Scott Whitt, MA, President and General Manager, Triad Clinical Trials
50 Shades of Gray – Remote Monitoring: Who is Accountable for What?
Remote monitoring is a reality and sites must understand the various interpretations. This session will highlight areas of responsibility for sponsor and site and what is required to ensure workload and ownership is appropriately managed.
Michele Cameron, RN, BSN, MBA, CCRC, Director, Clinical Research, Clearwater Cardiovascular Consultants
Roman Fishchuk, MD, MSc, CEO, Clinical Trials Unit, Central City Clinical Hospital of Ivano-Frankivsk City Council
Dementric Matthews, Vice President, Global Clinical Operations, Syneos Health
Andrew Onikepe, MS, Regional Director of Monitoring Excellence, Merck
Study Budgets 101: Make Sure You Are Getting the Best Budget for Your Site
It’s not about building a better mousetrap, but it is about knowing how to build a better study budget. Join this breakout to understand the costs related to clinical trials and learn how to invoice for your study-related activities. Leave with supporting forms and templates that will strengthen your budget negotiations and your bottom line.
Chris Hoyle, MBA, CEO & Founder, Elite Research Network
Kristen Andrews, Senior Director, Site Partnerships, Labcorp Drug Development
Todd Albin, MBA, CEO, Cedar Health Research
Kathy Cox, MS, President, Interspond
FDA Inspections: How to Prepare
Are you certain your site is ready for an FDA inspection? This session will include insights from FDA inspectors and sites that have been inspected. Learn what measures they have implemented to ensure you are inspection ready.
Karri Venn, RD, CCRC,COO, Centricity Research
Ana Marquez, MSF, CRCP, CEO, Clinical Site Partners, part of Flourish Research Orlando
Forecasting: Already Randomized, Future Randomizations & Pipeline
Find out if your site is missing valuable opportunities for future revenue. Join this discussion to find out how other sites are using tools to track revenue and how they forecast metrics to ensure they are managing their staff and study pipelines.
Steven Geller, MD, Medical Director, Centennial Medical Group
Todd Engelman, Sr. Manager Clinical Operations, PPD, part of Thermo Fisher Scientific
Karin Gulbrandsen, Sr. Director, US Head, Global Clinical Operations, Janssen
Anne-Marie Manasier, VP, Business Development, Clinical Site Partners, part of Flourish Research
Recent Direction & Importance of Completion of the Diversity Site Assessment Tool for Site Selection in Studies Enrolling Diverse Populations
Discuss sponsor and CRO philosophies on the importance of site benchmarking through the SCRS Diversity Site Assessment Tool (DSAT). Join us to learn how sites can improve business opportunities in diverse enrollment studies through DSAT methodology.
Amanda Rangel, MS, Sr. VP Business Development, Total Diversity Clinical Trial Management
Brandon Doyle, MBA, Associate Director Site Alliances, Parexel
Lloryn Hubbard, Director, Patient Diversity, PPD, part of Thermo Fisher Scientific
How to Build Strong Relationships of Trust
*BD & Relationships
Join this panel discussion on how to build strong industry relationships and explore the communication fundamentals. Learn how to develop genuine rapport with contacts for reciprocal alliances.
Dan Otap, Senior Alliance & Partnerships Lead, Genentech
Dana Edwards, CCO, Circuit Clinical
Natalie Monegro, MBA, MPH, Lead, Clinical Trial Diversity and Inclusion, AbbVie
Casey Orvin, CCO, Cenexel
Jeff Repper, EVP, Strategic Site Initiatives, TPS Global